Vulvodynia Clinical Trial
Official title:
Pilot Clinical Trial of Two Acupuncture Protocols on Vulvodynia
Vulvodynia is a common condition in women (16%); however, at this time there is no known
effective non-pharmacological therapy reported. Acupuncture is one complementary and
alternative medicine therapy used by many patients with vulvodynia; some case reports show
that acupuncture may be an effective intervention. In recent years, there were some studies
registered took at like at actual trials of acupuncture on vulvodynia, but either they did
not reach the trial aims, some studies did not get enough patients or the trial designs mimic
drug studies and did not reflect acupuncture real characteristics.
This study evaluates acupuncture for the treatment of vulvodynia; specifically, if it reduces
vulvar pain, pain duration and pain with intercourse. It also examines how long the effect of
acupuncture lasts in women with vulvodynia. One third of the women will receive acupuncture
focused on pudendal nerve distribution area; another one third of the women will receive
acupuncture focused on traditional meridian points; the other one third of women will use
standard care (without acupuncture). Women who get a reduction in pain (included in
subjective and objective scores) will have their pain monitored once a week for up to 6 weeks
to see if the acupuncture effect lasts.
Aims of this study:
1. Get preliminary data for future larger, randomized- controlled trials.
2. See whether acupuncture is better than no-acupuncture treatments (where participations
are following standard care for this condition), or at least have probable better
outcomes than no acupuncture treatment (there may not be significance in statistics,
given the small sample in current proposed trial);
3. See if acupuncture group 1a (with focus on the points in pudendal nerve distribution
near the pain area) has better results(at least, a trend) than acupuncture group 1b
(traditional acupuncture focus on meridian or distal points).
The basic design and interventions:
1. Diagnosis: Vulvodynia/Vulval pain by gynecologist or pain specialist/doctor, who will
adopt International diagnose criteria.
2. Patient sample (estimated): 17 in each acupuncture group (34 total), and 17 patients in
the no-acupuncture group or standard care waiting list . Total 51 patients;
3. Groups:
Group 1a (17 cases): acupuncture, using the local points in pudendal nerve distribution
area (tender points, and up to two other set of acupuncture points); Group 1b (17
cases): traditional acupuncture, using common meridian or distal points; Group 2 (17
cases): standard care, waiting list. This group will receive no acupuncture treatment.
4. Randomized method: If the patient feels comfortable with acupuncture, they will be
randomly assigned to either Group 1a or Group1b using randomization numbers generated by
computer; if the patients still are under the treatments of routine conventional
treatments, such as using pain medications, local injections, and physical therapies, or
other non-surgical procedure, they will serve as participants in the standard care
group, the waiting list.
5. Blind Method: Patients will be blind as to the purpose of the study as well as to the
groups that they are assigned too. Each participant in either group 1a or 1b will
receive actual, real acupuncture treatment but, depending on their group assignment, the
strategy and points used will vary.
6. Treatments:
Group 1a: acupuncture: needling focus on Hui yang, pudendal nerve points and local
point(s) near the pain location with needling manipulation (such as twisting 200/min for
2-5 minutes at pudendal nerve points); Group 1b: acupuncture: using meridian points,
focus on Xue Hai (SP9), San Yin Jiao (SP6), Zu San Li (ST36); Both groups also use: Shen
Ting (GV24), Tou Wei (ST 8), Yin Tang (EX2) for helping to release stress and create
calm.
Both group 1(a/b) and group 2 patients are all allowed to use pain medications (in which
the medications' name and how many pills used during 6 weeks' observation period will be
carefully document); the standard care group actually is a waiting list, without
acupuncture intervention. Follow up: 6 weeks.
Acupuncture time and frequency: 45 min per session, once or twice per week, for 6-12
sessions (in 6 weeks).
7. Main observation:
(1) Objective pain score(tested using cotton swab); (2) Patient self reported pain score
(subjective, before Cotton swab test); Others: Pain duration and pain score during
intercourse.
8. Statistics: student t-test.
Sample calculation: The expected difference (ECSD) between two means is 3, and the common
within group standard deviation is 3. Giving an 80 chance that an 0.05 level test of
significance will find a statistically significant difference between two sample means are
compared, the sample size is approximately 17 per group.
Comparisons:
1. At the end point (end of 6 weeks), make comparisons between acupuncture (1a+1b) group
and group 2, acupuncture 1a and group 2, acupuncture 1b and group 2; between acupuncture
1a and acupuncture 1b; respectively.
2. At the end point (end of 6 weeks), make comparisons in each group self (before and
after).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05478746 -
Effects of Flourish HEC on Localized Provoked Vulvodynia
|
N/A | |
Completed |
NCT02404961 -
Women's Health Study: Immunological Factors and Risk of Vulvodynia
|
||
Completed |
NCT00751010 -
Relationship: Interstitial Cystitis & Vulvodynia-Part 2
|
N/A | |
Completed |
NCT00607490 -
A Randomized Clinical Trial for Women With Vulvodynia
|
N/A | |
Recruiting |
NCT03640624 -
Multidisciplinary Treatment of Chronic Vulvar Pain
|
N/A | |
Recruiting |
NCT05343182 -
Vestibulectomy Surgical Techniques Comparison Study
|
N/A | |
Recruiting |
NCT05518630 -
An Investigation of Nomothetic Versus Idiographic Assessment in Chronic Pain
|
||
Recruiting |
NCT05597358 -
Efficacy of High Intensity Laser for Provoked Vestibulodynia
|
N/A | |
Completed |
NCT01304589 -
Savella in Treatment for Provoked Vestibulodynia
|
Phase 3 | |
Completed |
NCT00590590 -
Safety and Efficacy of Two Vaginal Products Versus Placebo in Patients With Vaginal Discomfort
|
Phase 2 | |
Recruiting |
NCT06138171 -
Personality, Defences, Central Sensitization, and Trauma in Women With Chronic Migraine, Fibromyalgia, and Vulvodynia
|
||
Completed |
NCT01996384 -
Provoked, Localized Vulvodynia Treatment With Acupuncture and Lidocaine Pilot Study
|
Phase 1 | |
Completed |
NCT01664962 -
Search for Genetic Basis of Vulvodynia
|
N/A | |
Recruiting |
NCT05955313 -
Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia
|
Phase 2 | |
Completed |
NCT02773641 -
Placebo-controlled RCT of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia
|
Phase 3 | |
Completed |
NCT00501774 -
A Search for Helicobacter Pylori in Localized Vulvodynia
|
N/A | |
Completed |
NCT04057755 -
Botulinum Toxin A as a Treatment for Provoked Vestibulodynia
|
Phase 3 | |
Terminated |
NCT04016467 -
Effect of Spinal Manipulation on Vulvar Pain
|
N/A | |
Completed |
NCT01935063 -
Study to Compare the Efficacy of Cognitive-behavioral Couple Therapy and Lidocaine for Provoked Vestibulodynia
|
N/A | |
Completed |
NCT02809612 -
An Internet-based Information Platform for Vulvodynia Patients
|
N/A |